Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-23-041191)

Filing Details

Accession Number:: 0001140361-23-041191
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-24 19:53:31
Reporting Period:: 2023-08-24

Accepted Time:: 2023-08-24 19:53:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1733094	Young Kwon	C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-24	25,000	$3.90	277,401	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023, that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date and (ii) 251,586 shares of common stock owned by the reporting person.